I agree that this site is using cookies. You can find further informations here.
X
Imazeki, Hiroshi
79  results:
Search for persons X
?
1

Efficacy and safety of mirogabalin for chemotherapy-induced..:

Misawa, Sonoko ; Denda, Tadamichi ; Kodama, Sho...
BMC Cancer.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
2

Protocol digest of a randomized controlled adaptive Phase I..:

Kita, Ryosuke ; Yanagimoto, Yoshitomo ; Imazeki, Hiroshi...
Japanese Journal of Clinical Oncology.  54 (2023)  2 - p. 206-211 , 2023
Link: https://doi.org/10.1093/..
 
?
3

Targeting AURKA in treatment of peritoneal tumor disseminat..:

Ozawa, Hiroki ; Imazeki, Hiroshi ; Ogiwara, Yamato...
Translational Oncology.  16 (2022)  - p. 101307 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Usefulness of an S-1 dosage formula: an exploratory analysi..:

Kawakami, Takeshi ; Mizusawa, Junki ; Hasegawa, Hiroko...
Gastric Cancer.  25 (2022)  6 - p. 1073-1081 , 2022
Link: https://doi.org/10.1007/..
 
?
5

CD11b+CTLA4+myeloid cells are a key driver of tumor evasion..:

Imazeki, Hiroshi ; Ogiwara, Yamato ; Kawamura, Mami..
Journal for ImmunoTherapy of Cancer.  9 (2021)  7 - p. e002841 , 2021
Link: https://doi.org/10.1136/..
 
?
6

Targeting Oncoimmune Drivers of Cancer Metastasis:

Kudo-Saito, Chie ; Ozaki, Yukinori ; Imazeki, Hiroshi...
Cancers.  13 (2021)  3 - p. 554 , 2021
Link: https://doi.org/10.3390/..
 
?
7

Tumor growth rate during re-challenge chemotherapy with pre..:

Ishikawa, Masashi ; Takashima, Atsuo ; Nagata, Yusuke...
PLOS ONE.  16 (2021)  9 - p. e0257551 , 2021
Link: https://doi.org/10.1371/..
 
?
8

Hyperprogressive disease during nivolumab or irinotecan tre..:

Aoki, Masahiko ; Shoji, Hirokazu ; Nagashima, Kengo...
ESMO Open.  4 (2019)  3 - p. e000488 , 2019
Link: https://doi.org/10.1136/..
 
?
9

Retrospective comparison of nab-paclitaxel plus ramucirumab..:

Ishikawa, Masashi ; Iwasa, Satoru ; Nagashima, Kengo...
Investigational New Drugs.  38 (2019)  2 - p. 533-540 , 2019
Link: https://doi.org/10.1007/..
 
?
10

Linked color imaging improves the endoscopic visibility of ..:

Kitagawa, Yoshiyasu ; Suzuki, Takuto ; Hara, Taro...
Endoscopy International Open.  7 (2019)  2 - p. E164-E170 , 2019
Link: https://doi.org/10.1055/..
 
?
11

Correlation between immune-related adverse events and progn..:

Masuda, Ken ; Shoji, Hirokazu ; Nagashima, Kengo...
BMC Cancer.  19 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
12

PS02.141: RESULTS AND PROSPECTS OF SALVAGE SURGERY AFTER DE..:

Nabeya, Yoshihiro ; Hoshino, Isamu ; Nagata, Matsuo...
Diseases of the Esophagus.  31 (2018)  Supplement_1 - p. 160-161 , 2018
Link: https://doi.org/10.1093/..
 
?
13

Initial experience of a new peroral pancreatoscopy (SpyGlas..:

Kita, Emiri ; Yamaguchi, Taketo ; Imazeki, Hiroshi...
Pancreatology.  16 (2016)  4 - p. S71 , 2016
Link: https://doi.org/10.1016/..
 
?
14

The outcome of responders to initial chemoradiotherapy or c..:

Sudo, Kentaro ; Nakamura, Kazuyoshi ; Kita, Emiri...
Pancreatology.  16 (2016)  4 - p. S32 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Gemcitabine plus nab-paclitaxel in patients with previously..:

Imazeki, Hiroshi ; Sudo, Kentaro
Pancreatology.  16 (2016)  4 - p. S174 , 2016
Link: https://doi.org/10.1016/..
 
1-15